Manifestation of Subclinical Extrapulmonary Tuberculosis after COVID-19 Vaccination as Supraclavicular Lymphadenopathyopen access
- Authors
- Cha, Han Gyu; Kim, Dong Gyu; Choi, Joon Ho
- Issue Date
- Jun-2022
- Publisher
- Multidisciplinary Digital Publishing Institute (MDPI)
- Keywords
- lymphadenopathy; COVID-19; vaccination; tuberculosis
- Citation
- Vaccines, v.10, no.6, pp 1 - 6
- Pages
- 6
- Journal Title
- Vaccines
- Volume
- 10
- Number
- 6
- Start Page
- 1
- End Page
- 6
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/21174
- DOI
- 10.3390/vaccines10060964
- ISSN
- 2076-393X
- Abstract
- Lymphadenopathy after coronavirus disease 2019 (COVID-19) vaccination is a common side effect that usually resolves within several days to weeks, and only observation is recommended. However, for prolonged lymphadenopathy, other possibilities, including malignancy or other lymphoproliferative diseases, may be considered. Herein, we report the case of a 66-year-old woman who experienced prolonged ipsilateral supraclavicular lymph node enlargement after the second dose of the ChAdOx1 (Oxford-AstraZeneca) COVID-19 vaccine, which was eventually diagnosed as extrapulmonary tuberculosis.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Plastic Surgery > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.